Geoff Meyerson to Moderate Panel at Crush Life Sciences Board Meeting
CATEGORIES News Events Publications ARCHIVE Geoff Meyerson to Moderate Panel at Crush Life Sciences Board Meeting The Crush Life Sciences […]
News
Market Trends
Global Business Reports Interview with Geoff Meyerson, CEO & Co-Founder of Locust Walk
Special Report on the U.S. Biopharmaceuticals Industry 2019
Selected quotes from the interview with Geoff Meyerson, CEO and Co-Founder of Locust Walk
Commercial Assessment
Greed is Bad: Why Defendable Commercial Assessments are Better Than Pie in the Sky
Clear, data-based financial assumptions are essential to driving a successful deal process. In a previous post, The Value of a Commercial Assessment in Supporting a Transaction
Multitrack Process
The Art of the Multi-Track Deal Whitepaper
Pursuing multiple deal options in parallel, known as a multi-track process, can create competitive tension that will enable a company to obtain the most value out of the deal
Market Trends
Make No Bones About It – AAOS 2019 Was All About M&A and Promising New Technology
It is that time of year again when the orthopedics community comes together to reflect on the recent American Academy of Orthopedic Surgeons (AAOS) meeting which took place in Las Vegas and finished late last week.
Asian Capabilities, Partnering
The Asia Factor Whitepaper
In this whitepaper, you’ll discover China and Japan are combining to invigorate the deal making landscape in Asia, even though their biopharma ecosystem dynamics are markedly different. Regardless, they are affecting deal making strategies globally.
Uncategorized
Locust Walk Expands Medtech Team with the Appointment of Howard Hechler
About Our Name Locust Walk is the central artery of the University of Pennsylvania campus, a well-known, tree-lined brick pathway
Events, News
Hayato Watanabe, Locust Walk’s SVP, Head of Asia, to Speak on a Panel at BIO Asia
CATEGORIES News Events Publications ARCHIVE Hayato Watanabe, Locust Walk’s SVP, Head of Asia, to Speak on a Panel at BIO
Market Trends, Negotiation
Trends in Venture Deal Term Sheets: Favorable Climate for Founders
If you are raising capital now, the path you are about to embark on can be stressful and littered with obstacles, but the light at the end of the tunnel is worth the trials and tribulations.
News
Fireside Chat with Geoff Meyerson, Locust Walk’s CEO & Co-Founder, at BIO CEO & Investor Conference
CATEGORIES News Events Publications ARCHIVE Fireside Chat with Geoff Meyerson, Locust Walk’s CEO & Co-Founder, at BIO CEO & Investor